CARBAGLU DIN 02439360
Health Canada record
| Active ingredient(s) | CARGLUMIC ACID 200 MG |
|---|---|
| Dosage form | Tablet For Suspension |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A16AA05 CARGLUMIC ACID |
| Original market date | 08-Sep-2015 |
| Current status date | 17-Mar-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Recordati Rare Diseases Canada Inc. — licence 102167, currently licensed, last inspection rating C (2022-08-17).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22524 | 2019-08-12 | New Drug Submission (NDS) | Administrative: Manufacturer Name Change |
| 16783 | 2015-04-10 | New Drug Submission (NDS) |
International API supply for CARGLUMIC ACID
5 active FDA Drug Master Files.
Request a quote for CARBAGLU